HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Hillsdale Investment Management Inc.'s Holding History (CIK: 0001368465)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 107,450 Value ($000) $7,231 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 94,000 Value ($000) $6,894 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 94,400 Value ($000) $4,911 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 98,000 Value ($000) $6,253 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 106,200 Value ($000) $5,077 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 106,100 Value ($000) $6,073 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 108,400 Value ($000) $5,676 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 112,900 Value ($000) $4,593 Avg Close $37.49 Range $33.15 - $42.64
Q1 2021
Shares 77,800 Value ($000) $3,243 Avg Close $45.65 Range $38.80 - $56.40
Q4 2020
Shares 77,000 Value ($000) $3,289 Avg Close $35.95 Range $25.70 - $44.53
Q4 2019
Shares 43,300 Value ($000) $768 Avg Close $17.32 Range $14.61 - $19.73
Q3 2019
Shares 49,300 Value ($000) $765 Avg Close $16.47 Range $15.07 - $17.79